Readily Secures $11M for Compliance Intelligence Platform
The Series A round was led by Define Ventures, with participation from Y Combinator and the California Health Care Foundation Innovation Fund.
The Series A round was led by Define Ventures, with participation from Y Combinator and the California Health Care Foundation Innovation Fund.
AdvaMed CEO Scott Whitaker outlined four policy priorities at the MedTech Conference: tariffs, FDA user fees, payment and coverage, and cybersecurity.
Allswell's seed round was led by Rethink Impact, and included participation from Magnify Ventures, Ulu Ventures and Hopelab Ventures, joining existing investors Techstars and Amboy Street Ventures.
Epic will launch a tool in summer 2027 to help patients compare prescription cash prices and insurance costs across pharmacies.
Rosarium Health partnered with Anthem Medi-Cal to provide home safety modifications for eligible members.
HealthTap launched a virtual care program to support sleep equipment suppliers and patients using PAP therapy.
Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction.
Outro’s funding included participation from Listen Ventures, Cake Ventures, Jason Calicanis’s LAUNCH, Actions Capital, Hannah Grey Ventures, SemperVirens, Brock Recovery Group and Pave Health Ventures.
The Series A round was led by Oak HC/FT, with participation from Norwest, .406 Ventures, Constellation Ventures, Y Combinator, Rock Health Capital and MemorialCare Innovation Fund.
Trilliant Health’s report identifies six trends highlighting how misaligned incentives are contributing to rising costs, poor health outcomes, workforce shortages and other systemic problems in U.S. healthcare.
The FTC sent warning letters to 24 major healthcare organizations over concerns about inadequate price transparency.
The Trump administration is issuing one-time $90 payments to more than 20 million Medicare beneficiaries to help cover Part B premiums, though the payments may do little to offset rising healthcare costs.
The Trump administration’s ACA fraud crackdown will remove 760,000 people from Marketplace coverage, drawing criticism from healthcare experts and advocates.
The Series A round was led by Canvas Ventures, with participation from Blank Space Ventures, StoryHouse Ventures and HMC INQ.
The AMA found that OptumRx, Express Scripts, CVS Caremark and Prime Therapeutics controlled 75% of the national PBM market in 2024.
In this episode, we’re joined by Claire Love, deals strategy principal at PwC. We discuss PwC’s recent report showing the opportunities in the fertility and reproductive health market.